SLC2A1 and central nervous system cancer: Targeting glycolysis‐associated proteins, such as lactate dehydrogenase A (LDHA), glucose transporter type 1 (GLUT1), and pyruvate kinase M2 (PKM2), may impede the migration and invasion of glioma cells.35, 36, 37